SABS - SAB Biotherapeutics, Inc.

QQQ $ 613.36 $ -9.99 (-1.61 %)

DIA $ 470.23 $ -2.78 (-0.59 %)

SPY $ 671.96 $ -6.30 (-0.93 %)

TLT $ 89.61 $ 0.21 (0.23 %)

GLD $ 367.27 $ -1.11 (-0.3 %)

Previous Close

$ 3.1

Open

$ 3.15

Bid

$ 2.74 x 100

Ask

$ 3.03 x 6,734

Day's Range

$ 2.84 - $ 3.15

52 Week Range

$ 1.00 - $ 6.60

Volume

376,882

Average Volume

Market Cap

32.27M

Beta (5Y Monthly)

$ 1.38

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-09-2025	03-31-2025	10-Q
3	03-28-2025	12-31-2024	10-K
4	11-06-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-20-2024	03-31-2024	10-Q
7	03-28-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-21-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	04-14-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-10-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-29-2022	12-31-2021	10-K
16	11-22-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-21-2021	03-31-2021	10-Q
19	04-02-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

SAB Biotherapeutics To Present Phase 1 Dat...
11/04/2025 13:37:18

SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobu...

12 Health Care Stocks Moving In Friday's A...
10/03/2025 21:05:59

12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 21:06:48

12 Health Care Stocks Moving In Tuesday's ...
09/23/2025 21:07:00

12 Health Care Stocks Moving In Friday's A...
09/19/2025 21:06:05

12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

Chardan Capital Maintains Buy on SAB Bioth...
09/19/2025 15:59:31

Chardan Capital analyst Keay Nakae maintains SAB Biotherapeutics (NASDAQ:SABS) with a Buy and maintains $12 price target.

SAB Biotherapeutics Showcases SAB-142 Data...
09/19/2025 11:28:35

Leerink Partners Initiates Coverage On SAB...
09/17/2025 12:20:08

Leerink Partners initiates coverage on SAB Biotherapeutics (NASDAQ:SABS) with a Outperform rating and announces Price Target ...

SAB Biotherapeutics To Present At The 61st...
09/03/2025 20:18:36

MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), ("SAB BIO" or the "Company"...

12 Health Care Stocks Moving In Wednesday'...
09/03/2025 12:08:15

Chardan Capital Maintains Buy on SAB Bioth...
08/08/2025 12:02:41

Chardan Capital analyst Keay Nakae maintains SAB Biotherapeutics (NASDAQ:SABS) with a Buy and lowers the price target from $...

SAB Biotherapeutics Q2 EPS $(1.09) Misses ...
08/07/2025 11:54:06

12 Health Care Stocks Moving In Wednesday'...
07/23/2025 12:08:15

HC Wainwright & Co. Maintains Buy on SAB B...
07/22/2025 10:21:19

HC Wainwright & Co. analyst Emily Bodnar maintains SAB Biotherapeutics (NASDAQ:SABS) with a Buy and lowers the price tar...

12 Health Care Stocks Moving In Monday's P...
07/21/2025 12:08:15

SAB BIO Raises $175M In Oversubscribed Pri...
07/21/2025 11:36:39

Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, ...

12 Health Care Stocks Moving In Thursday's...
05/29/2025 21:06:36

12 Health Care Stocks Moving In Wednesday'...
05/21/2025 21:06:07

Chardan Capital Maintains Buy on SAB Bioth...
05/15/2025 15:31:33

Chardan Capital analyst Keay Nakae maintains SAB Biotherapeutics (NASDAQ:SABS) with a Buy and maintains $20 price target.